We are live on ! Find out more
EAM

EULAV Asset Management Portfolio holdings

AUM $3.13B
1-Year Est. Return 23.04%
This Fund
S&P 500
This Quarter Est. Return
-0.63%
1 Year Est. Return
+23.04%
3 Year Est. Return
+90.7%
5 Year Est. Return
+115.08%
10 Year Est. Return
+583.23%
AUM
$1.84B
AUM Growth
-$27.2M
Cap. Flow
+$4.14M
Cap. Flow %
0.22%
Top 10 Hldgs %
9.64%
Holding
397
New
18
Increased
106
Reduced
77
Closed
48

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$5.07M
2
SAP icon
SAP
SAP
+$4.61M
3
NVO
Novo Nordisk
NVO
+$4.14M
4
MA icon
Mastercard
MA
+$4.07M
5
ORCL icon
Oracle
ORCL
+$4.03M

Sector Composition

Rank Sector Weight
1 Industrials 23.06%
2 Consumer Discretionary 14.02%
3 Healthcare 12.71%
4 Technology 11.4%
5 Financials 9.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DVA icon
326
DaVita
DVA
$11.4B
$570K 0.03%
7,800
RH icon
327
RH
RH
$3.45B
$557K 0.03%
+7,000
New +$585K
JNJ icon
328
Johnson & Johnson
JNJ
$626B
$533K 0.03%
5,000
-36,100
-88% -$3.74M
ESGR
329
DELISTED
Enstar Group
ESGR
$532K 0.03%
3,900
+300
+8% +$42.8K
EV
330
DELISTED
Eaton Vance Corp.
EV
$528K 0.03%
14,000
CEO
331
DELISTED
CNOOC Limited
CEO
$449K 0.02%
2,600
-1,800
-41% -$332K
RNR icon
332
RenaissanceRe
RNR
$13.2B
$400K 0.02%
4,000
BRLI
333
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
$398K 0.02%
14,200
ACC
334
DELISTED
American Campus Communities, Inc.
ACC
$379K 0.02%
10,400
BOKF icon
335
BOK Financial
BOKF
$8.76B
$372K 0.02%
5,600
SPB icon
336
Spectrum Brands
SPB
$2.03B
$362K 0.02%
4,000
RYAAY icon
337
Ryanair
RYAAY
$30.8B
$339K 0.02%
14,625
+2,437
+20% +$54.3K
OIS icon
338
Oil States International
OIS
$533M
$309K 0.02%
5,000
NWE icon
339
NorthWestern Energy
NWE
$4.37B
$308K 0.02%
6,800
SKT icon
340
Tanger
SKT
$4.43B
$294K 0.02%
9,000
+3,000
+50% +$104K
NTCT icon
341
NETSCOUT
NTCT
$2.8B
$293K 0.02%
+6,400
New +$287K
UGP icon
342
Ultrapar
UGP
$6.37B
$245K 0.01%
23,200
-38,000
-62% -$451K
CMP icon
343
Compass Minerals
CMP
$1.13B
$228K 0.01%
2,700
EG icon
344
Everest Group
EG
$14B
$227K 0.01%
1,400
AMP icon
345
Ameriprise Financial
AMP
$49.8B
-9,700
Closed -$1.16M
BEN icon
346
Franklin Resources
BEN
$17B
-40,000
Closed -$2.31M
BIO icon
347
Bio-Rad Laboratories Class A
BIO
$9.58B
-5,600
Closed -$670K
CTAS icon
348
Cintas
CTAS
$82.4B
-93,600
Closed -$1.49M
DUK icon
349
Duke Energy
DUK
$96B
-28,333
Closed -$2.1M
EPAC icon
350
Enerpac Tool Group
EPAC
$1.91B
-53,000
Closed -$1.83M

Similar funds

EULAV Asset Management's Q3 2014 Portfolio in Review

As of Q3 2014, EULAV Asset Management held 397 positions worth $1.84B, down 1.5% from $1.87B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

EULAV Asset Management's Q3 2014 filing shows 18 new, 106 increased, 77 reduced and 48 closed positions. Its largest new stake was Celgene Corp: 133,000 shares worth $12.6M. The largest sale was UnitedHealth, an estimated $5.07M.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • EULAV Asset Management's largest Q3 2014 buy was Celgene Corp: 133,000 shares worth $12.6M.
  • EULAV Asset Management added most to Trimble in Q3 2014, an estimated $7.8M increase.
  • EULAV Asset Management's biggest Q3 2014 reduction was Novo Nordisk, cutting an estimated $4.14M.
  • EULAV Asset Management fully exited UnitedHealth in Q3 2014, selling an estimated $5.07M.
  • EULAV Asset Management's ten largest holdings make up 9.6% of its $1.84B portfolio in Q3 2014.
  • EULAV Asset Management opened 18 new positions and closed 48 in Q3 2014.
  • EULAV Asset Management's portfolio value fell 1.5% quarter-over-quarter to $1.84B.

Based on EULAV Asset Management's 13F filing for Q3 2014, filed 17 Nov 2014.